| __timestamp | Amneal Pharmaceuticals, Inc. | Amphastar Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 28427000 |
| Thursday, January 1, 2015 | 136870000 | 37065000 |
| Friday, January 1, 2016 | 204747000 | 41199000 |
| Sunday, January 1, 2017 | 191938000 | 43415000 |
| Monday, January 1, 2018 | 210451000 | 57564000 |
| Tuesday, January 1, 2019 | 202287000 | 68853000 |
| Wednesday, January 1, 2020 | 190585000 | 67229000 |
| Friday, January 1, 2021 | 209563000 | 60932000 |
| Saturday, January 1, 2022 | 200046000 | 74771000 |
| Sunday, January 1, 2023 | 167778000 | 73741000 |
Unleashing insights
In the competitive landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Amneal Pharmaceuticals, Inc. and Amphastar Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amneal consistently outpaced Amphastar, investing nearly three times more in R&D on average. However, Amphastar has shown a remarkable growth trajectory, increasing its R&D spending by over 160% from 2014 to 2023. This strategic shift highlights Amphastar's commitment to innovation and market expansion. Meanwhile, Amneal's investment peaked in 2018, with a slight decline in recent years, possibly indicating a shift towards optimizing existing products. As the pharmaceutical industry continues to evolve, these investment patterns may shape the future landscape of drug development and market leadership.
Comparing Innovation Spending: Pfizer Inc. and Amneal Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Amphastar Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
R&D Insights: How argenx SE and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Biogen Inc. vs Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Lantheus Holdings, Inc. vs Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Corcept Therapeutics Incorporated vs Amneal Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
Comparing Cost of Revenue Efficiency: Amneal Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
R&D Insights: How Amneal Pharmaceuticals, Inc. and Evotec SE Allocate Funds
Amphastar Pharmaceuticals, Inc. vs Evotec SE: Strategic Focus on R&D Spending